Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists

dc.contributor.authorDiacon A.H.
dc.contributor.authorSchuurmans M.M.
dc.contributor.authorTheron J.
dc.contributor.authorSchubert P.T.
dc.contributor.authorWright C.A.
dc.contributor.authorBolliger C.T.
dc.date.accessioned2011-05-15T15:57:32Z
dc.date.available2011-05-15T15:57:32Z
dc.date.issued2004
dc.description.abstractBackground: Transthoracic ultrasound (US) has gained popularity as a tool for visualizing pleural effusions and assisting thoracentesis or chest drain placement. In the absence of effusion, US just as well demonstrates solid masses involving or abutting the pleura, yet biopsy of such lesions is not widely performed by chest physicians. Objective: To assess the feasibility and the safety of US-assisted cutting needle biopsy performed by chest physicians in routine practice. Methods: Lesions involving or abutting the pleura ≥20 mm in diameter on US were sampled with a 14-gauge cutting needle under local anesthesia. Biopsy site, needle direction and depth of penetration were determined with US. The procedure was performed without direct US guidance in 'free-hand' technique. Results: Ninety-one patients underwent 96 cutting-needle biopsies for suspected peripheral lung tumors (n = 44, 46%), pleural-based (n = 39, 41%), mediastinal (n = 10, 10%), or chest wall lesions (n = 3, 3%), which were single in 71%, multiple in 6% and diffuse in 23%. Sensitivity for malignant neoplasms (n = 65) was 85.5% and 100% for mesothelioma (n = 10). Pneumothorax occurred in 4%. Conclusions: US-assisted cutting-needle biopsy of lesions ≥20 mm in diameter is safe in the hands of pulmonologists. The yield for neoplastic disease including mesothelioma is high. Copyright © 2004 S. Karger AG, Basel.
dc.description.versionArticle
dc.identifier.citationRespiration
dc.identifier.citation71
dc.identifier.citation5
dc.identifier.issn257931
dc.identifier.other10.1159/000080638
dc.identifier.urihttp://hdl.handle.net/10019.1/10456
dc.subjectbronchodilating agent
dc.subjectadult
dc.subjectaged
dc.subjectarticle
dc.subjectbleeding
dc.subjectclinical practice
dc.subjectclinical trial
dc.subjectdyspnea
dc.subjectfemale
dc.subjectfibroma
dc.subjecthand
dc.subjecthemoptysis
dc.subjecthuman
dc.subjectlocal anesthesia
dc.subjectlung fibrosis
dc.subjectlung metastasis
dc.subjectlung non small cell cancer
dc.subjectlung sarcoma
dc.subjectlung small cell cancer
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmediastinum disease
dc.subjectmesothelioma
dc.subjectmyeloma
dc.subjectneedle biopsy
dc.subjectpain
dc.subjectphysician
dc.subjectpleura tumor
dc.subjectpneumothorax
dc.subjectpriority journal
dc.subjectsafety
dc.subjectsample
dc.subjectsensitivity analysis
dc.subjectthorax wall defect
dc.subjecttransbronchial biopsy
dc.subjecttuberculoma
dc.subjectultrasound
dc.subjectwound
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectBiopsy, Needle
dc.subjectFeasibility Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectLung
dc.subjectLung Neoplasms
dc.subjectMale
dc.subjectMesothelioma
dc.subjectMiddle Aged
dc.subjectPleura
dc.subjectPneumothorax
dc.subjectProspective Studies
dc.subjectPulmonary Disease (Specialty)
dc.subjectSensitivity and Specificity
dc.subjectSurgery, Computer-Assisted
dc.subjectUltrasonography
dc.titleSafety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists
dc.typeArticle
Files